Post by Evotec

124,631 followers

We're back from an inspiring week at ISSCR 2026! Our team had a fantastic time connecting with researchers, partners, and innovators from across the stem cell and cell therapy community. ๐Ÿ’ก How do we translate the promise of stem cell science into meaningful impact for patients? We explored this question through two highly attended sessions at the event, focused on the opportunities and challenges shaping the future of drug discovery and regenerative medicine. ๐—ฅ๐—ฒ๐˜๐—ต๐—ถ๐—ป๐—ธ๐—ถ๐—ป๐—ด ๐——๐—ถ๐˜€๐—ฒ๐—ฎ๐˜€๐—ฒ ๐—•๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ง๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐—›๐˜‚๐—บ๐—ฎ๐—ป ๐——๐—ถ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ถ๐˜๐˜†: ๐—ต๐—ฃ๐—ฆ๐—– ๐—ฃ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ๐˜€ ๐—ง๐—ฟ๐—ฎ๐—ป๐˜€๐—ณ๐—ผ๐—ฟ๐—บ๐—ถ๐—ป๐—ด ๐——๐—ฟ๐˜‚๐—ด ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† Hosted by Bastian Zimmer, PhD, this session explored how human pluripotent stem cell (hPSC) platforms can incorporate genetic and population diversity into drug discovery, enabling disease models that better reflect real-world human variation. We would like to thank Janine Scholefield, Maneesha Inamdar, Shuibing Chen, and Todd Herron for sharing their perspectives and insights on advancing disease modelling and therapeutic discovery through diverse stem cell resources. ๐—ฆ๐˜๐—ฟ๐—ฎ๐˜๐—ฒ๐—ด๐—ถ๐—ฒ๐˜€ ๐—ณ๐—ผ๐—ฟ ๐—ถ๐—ฃ๐—ฆ๐—–-๐—•๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ฅ๐—ฒ๐—ด๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ถ๐—ฒ๐˜€ โ€“ ๐—™๐—ฟ๐—ผ๐—บ ๐—ฆ๐—ถ๐—ป๐—ด๐—น๐—ฒ ๐—–๐—ฒ๐—น๐—น๐˜€ ๐˜๐—ผ ๐—ข๐—ฟ๐—ด๐—ฎ๐—ป๐—ผ๐—ถ๐—ฑ๐˜€ Hosted by Audrey Holtzinger, this session highlighted recent advances in iPSC-derived regenerative therapies, spanning single-cell replacement approaches, multicellular systems, and organoid-based strategies. Many thanks to Terri Gaskell, Cristina Nostro, and Tomomi Tadokoro for their contributions and for discussing both scientific progress and key translational considerations on the path toward clinical application for hearing loss, diabetes and liver fibrosis. The strong attendance and active exchange throughout both sessions underscored the momentum behind human-relevant stem cell platforms and their potential to transform the way we discover and develop new therapies. Thank you to all speakers and attendees for contributing to these engaging discussions. ๐Ÿ”— ๐—ง๐—ผ ๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฒ ๐˜๐—ต๐—ฒ ๐—ฐ๐—ผ๐—ป๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฎ๐˜๐—ถ๐—ผ๐—ป, ๐˜ƒ๐—ถ๐˜€๐—ถ๐˜ ๐—ผ๐˜‚๐—ฟ ๐—œ๐—ฆ๐—ฆ๐—–๐—ฅ ๐—ฒ๐˜ƒ๐—ฒ๐—ป๐˜ ๐—ฝ๐—ฎ๐—ด๐—ฒ: https://okt.to/4sxvSW ๐˜„๐—ต๐—ฒ๐—ฟ๐—ฒ ๐˜†๐—ผ๐˜‚ ๐—ฐ๐—ฎ๐—ป: ๐Ÿ”นReview the session agendas ๐Ÿ”นDownload our latest Drug Discovery and Cell Therapy posters, presented at #ISSCR2026 ๐Ÿ”นConnect with our team to discuss potential collaborations and scientific opportunities https://okt.to/uUyfp8 #iPSC #CellTherapy #DrugDiscovery

Post contentPost contentPost contentPost contentPost content